0001610717-23-000053.txt : 20230519 0001610717-23-000053.hdr.sgml : 20230519 20230519170258 ACCESSION NUMBER: 0001610717-23-000053 CONFORMED SUBMISSION TYPE: 4 PUBLIC DOCUMENT COUNT: 1 CONFORMED PERIOD OF REPORT: 20230517 FILED AS OF DATE: 20230519 DATE AS OF CHANGE: 20230519 REPORTING-OWNER: OWNER DATA: COMPANY CONFORMED NAME: ROBERTS BRYAN E CENTRAL INDEX KEY: 0001239242 FILING VALUES: FORM TYPE: 4 SEC ACT: 1934 Act SEC FILE NUMBER: 001-39035 FILM NUMBER: 23941320 MAIL ADDRESS: STREET 1: C/O VENROCK ASSOCIATES STREET 2: 2494 SAND HILL ROAD STE 200 CITY: MENLO PARK STATE: CA ZIP: 94025 ISSUER: COMPANY DATA: COMPANY CONFORMED NAME: 10x Genomics, Inc. CENTRAL INDEX KEY: 0001770787 STANDARD INDUSTRIAL CLASSIFICATION: LABORATORY ANALYTICAL INSTRUMENTS [3826] IRS NUMBER: 455614458 STATE OF INCORPORATION: DE FISCAL YEAR END: 1231 BUSINESS ADDRESS: STREET 1: 6230 STONERIDGE MALL ROAD CITY: PLEASANTON STATE: CA ZIP: 94588 BUSINESS PHONE: (925) 401-7300 MAIL ADDRESS: STREET 1: 6230 STONERIDGE MALL ROAD CITY: PLEASANTON STATE: CA ZIP: 94588 FORMER COMPANY: FORMER CONFORMED NAME: 10X Genomics, Inc. DATE OF NAME CHANGE: 20190315 4 1 form4.xml X0407 4 2023-05-17 0001770787 10x Genomics, Inc. TXG 0001239242 ROBERTS BRYAN E C/O 10X GENOMICS, INC. 6230 STONERIDGE MALL ROAD PLEASANTON CA 94588 true false Class A Common Stock 2023-05-17 4 C 0 3790422 0 A 3790422 I By Funds Class A Common Stock 411205 I By Trusts Class A Common Stock 86638 D Class B Common Stock 2023-05-17 4 C 0 3790422 0 D Class A Common Stock 3790422 0 I By Funds Each share of Class B Common Stock is convertible at any time at the option of the Reporting Person into one share of Class A Common Stock and has no expiration date. Additionally, each share of Class B Common Stock will convert automatically into one share of Class A Common Stock upon transfer, whether or not for value (subject to certain exceptions) and upon the occurrence of certain other events set forth in the Issuer's Amended and Restated Certificate of Incorporation. On May 10, 2023, Venrock Associates VI, L.P. ("VA VI") and Venrock Partners VI, L.P. ("VP VI") distributed an aggregate of 1,037,825 shares of Class A Common Stock to their limited partners and general partners. Of the 1,037,825 shares distributed, 962,309 shares were distributed by VA VI to its general partner, Venrock Management VI, LLC ("VM VI") and 75,516 shares were distributed by VP VI to its general partner, Venrock Partners Management VI, LLC ("VPM VI"). Represents (a) 3,514,480 shares of Class A common stock held by VA VI and (b) 275,942 shares of Class A common stock held by VP VI. VM VI is the sole general partner of VA VI. VPM VI is the sole general partner of VP VI. The Reporting Person is a member of VM VI and VPM VI and disclaims beneficial ownership over all shares held by VA VI and VP VI, except to the extent of his indirect pecuniary interests therein. These shares are held by trusts for the benefit of the Reporting Person and his family members. On May 12, 2023, the Reporting Person received an aggregate of 83,893 shares of Class A Common Stock as part of the distribution of shares of VM VI and VPM VI. Represents (a) 83,893 shares of Class A common stock held directly by the Reporting Person and (b) 2,745 shares of Class A common stock held on behalf of VR Management, LLC (the "Management Company"). The Reporting Person is a member of the Management Company. Under an agreement between the Reporting Person and the Management Company, the Reporting Person is deemed to hold the reported shares for the sole benefit of the Management Company and must exercise the reported shares solely upon the direction of the Management Company, which is entitled to the shares. The Management Company may be deemed the indirect beneficial owner of the reported shares, and the Reporting Person may be deemed the indirect beneficial owner of the reported shares through his interest in the Management Company. The Reporting Person disclaims beneficial ownership of the reported shares except to the extent of his pecuniary interest therein. Represents (a) 0 shares of Class B common stock held by VA VI and (b) 0 shares of Class B common stock held by VP VI. VM VI is the sole general partner of VA VI. VPM VI is the sole general partner of VP VI. Dr. Roberts is a member of VM VI and VPM VI and disclaims beneficial ownership over all shares held by VA VI and VP VI, except to the extent of his indirect pecuniary interests therein. /s/ Bryan E. Roberts 2023-05-19